Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5976-5984

  Baccala, Roberto ^a   Gonzalez Quintial, Rosana ^a   Schreiber, Robert D ^a   Lawson, Brian R ^b   Kono, Dwight H ^a   Theofilopoulos, Argyrios N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; ALPHA INTERFERON; BETA INTERFERON; IMMUNOMODULATING AGENT; INTERFERON; INTERFERON ALPHA BETA RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA INTERFERON GENE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GENE DELETION; GENE DUPLICATION; IMMUNOMODULATION; LUPUS ERYTHEMATOSUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TOLL LIKE RECEPTOR 7 GENE; TREATMENT DURATION;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CELLS, CULTURED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, INBRED NZB; MICE, KNOCKOUT; PROTEINURIA; RECEPTOR, INTERFERON ALPHA-BETA;

EID: 84871122731     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201477     Document Type: Article

References (56)

1. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336. (Pubitemid 40563172)
2. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392. (Pubitemid 44354221)
3. Rönnblom, L., M. L. Eloranta, and G. V. Alm. 2006. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 54: 408-420. (Pubitemid 43228615)
4. Marshak-Rothstein, A., and I. R. Rifkin. 2007. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25: 419-441. (Pubitemid 46697913)
5. Baccala, R., K. Hoebe, D. H. Kono, B. Beutler, and A. N. Theofilopoulos. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13: 543-551. (Pubitemid 46828489)
6. Theofilopoulos, A. N., D. H. Kono, B. Beutler, and R. Baccala. 2011. Intracellular nucleic acid sensors and autoimmunity. J. Interferon Cytokine Res. 31: 867-886.
7. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428. (Pubitemid 44354217)
8. Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197: 777-788. (Pubitemid 36350872)
9. Braun, D., P. Geraldes, and J. Demengeot. 2003. Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20: 15-25. (Pubitemid 36207624)
10. Kono, D. H., M. K. Haraldsson, B. R. Lawson, K. M. Pollard, Y. T. Koh, X. Du, C. N. Arnold, R. Baccala, G. J. Silverman, B. A. Beutler, and A. N. Theofilopoulos. 2009. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 106: 12061-12066.
11. Sheehan, K. C., K. S. Lai, G. P. Dunn, A. T. Bruce, M. S. Diamond, J. D. Heutel, C. Dungo-Arthur, J. A. Carrero, J. M. White, P. J. Hertzog, and R. D. Schreiber. 2006. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26: 804-819. (Pubitemid 44764543)
12. Gonzalez-Quintial, R., B. R. Lawson, J. C. Scatizzi, J. Craft, D. H. Kono, R. Baccala, and A. N. Theofilopoulos. 2011. Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade. PLoS ONE 6: e27528.
13. Janssen, E., K. Tabeta, M. J. Barnes, S. Rutschmann, S. McBride, K. S. Bahjat, S. P. Schoenberger, A. N. Theofilopoulos, B. Beutler, and K. Hoebe. 2006. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 24: 787-799. (Pubitemid 43867366)
14. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148: 1198-1215.
15. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672. (Pubitemid 43902669)
16. Subramanian, S., K. Tus, Q. Z. Li, A. Wang, X. H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103: 9970-9975. (Pubitemid 43993607)
17. Basu, L., C. H. Yang, A. Murti, J. V. Garcia, E. Croze, S. N. Constantinescu, J. E. Mullersman, and L. M. Pfeffer. 1998. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation. Virology 242: 14-21. (Pubitemid 28396354)
18. Kumar, K. G., W. Tang, A. K. Ravindranath, W. A. Clark, E. Croze, and S. Y. Fuchs. 2003. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J. 22: 5480-5490. (Pubitemid 37279957)
19. Marijanovic, Z., J. Ragimbeau, J. van der Heyden, G. Uzé, and S. Pellegrini. 2007. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem. J. 407: 141-151. (Pubitemid 47535589)
20. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390. (Pubitemid 15093080)
21. Hao, Y., P. O'Neill, M. S. Naradikian, J. L. Scholz, and M. P. Cancro. 2011. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118: 1294-1304.
22. + B-cell population is important for the development of autoimmunity. Blood 118: 1305-1315.
23. Amano, H., E. Amano, T. Moll, D. Marinkovic, N. Ibnou-Zekri, E. Martinez-Soría, I. Semac, T. Wirth, L. Nitschke, and S. Izui. 2003. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J. Immunol. 170: 2293-2301. (Pubitemid 36245614)
24. Deane, J. A., P. Pisitkun, R. S. Barrett, L. Feigenbaum, T. Town, J. M. Ward, R. A. Flavell, and S. Bolland. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810. (Pubitemid 350102256)
25. Santiago-Raber, M. L., S. Kikuchi, P. Borel, S. Uematsu, S. Akira, B. L. Kotzin, and S. Izui. 2008. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J. Immunol. 181: 1556-1562.
26. Wofsy, D., C. E. Kerger, and W. E. Seaman. 1984. Monocytosis in the BXSB model for systemic lupus erythematosus. J. Exp. Med. 159: 629-634. (Pubitemid 14194001)
27. Hron, J. D., and S. L. Peng. 2004. Type I IFN protects against murine lupus. J. Immunol. 173: 2134-2142. (Pubitemid 38971652)
28. Baechler, E. C., P. K. Gregersen, and T. W. Behrens. 2004. The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16: 801-807. (Pubitemid 39423672)
29. Kirou, K. A., C. Lee, S. George, K. Louca, M. G. Peterson, and M. K. Crow. 2005. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52: 1491-1503. (Pubitemid 40663941)
30. Zhuang, H., S. Narain, E. Sobel, P. Y. Lee, D. C. Nacionales, K. M. Kelly, H. B. Richards, M. Segal, C. Stewart, M. Satoh, and W. H. Reeves. 2005. Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin. Immunol. 117: 238-250. (Pubitemid 43005210)
31. Nikpour, M., A. A. Dempsey, M. B. Urowitz, D. D. Gladman, and D. A. Barnes. 2008. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann. Rheum. Dis. 67: 1069-1075.
32. Petri, M., S. Singh, H. Tesfasyone, R. Dedrick, K. Fry, P. Lal, G. Williams, J. Bauer, P. Gregersen, T. Behrens, and E. Baechler. 2009. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 18: 980-989.
33. Obermoser, G., and V. Pascual. 2010. The interferon-alpha signature of systemic lupus erythematosus. Lupus 19: 1012-1019.
34. Mathian, A., A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov. 2005. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J. Immunol. 174: 2499-2506. (Pubitemid 40279662)
35. Fairhurst, A. M., A. Mathian, J. E. Connolly, A. Wang, H. F. Gray, T. A. George, C. D. Boudreaux, X. J. Zhou, Q. Z. Li, S. Koutouzov, et al. 2008. Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur. J. Immunol. 38: 1948-1960.
36. Ramanujam, M., P. Kahn, W. Huang, H. Tao, M. P. Madaio, S. M. Factor, and A. Davidson. 2009. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. Arthritis Rheum. 60: 1096-1101.
37. Jacob, N., S. Guo, A. Mathian, M. N. Koss, S. Gindea, C. Putterman, C. O. Jacob, and W. Stohl. 2011. B Cell and BAFF dependence of IFN-α- exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J. Immunol. 186: 4984-4993.
38. Nagata, S. 1999. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33: 29-55. (Pubitemid 30083118)
39. Fairhurst, A. M., S. H. Hwang, A. Wang, X. H. Tian, C. Boudreaux, X. J. Zhou, J. Casco, Q. Z. Li, J. E. Connolly, and E. K. Wakeland. 2008. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38: 1971-1978.
40. Peterson, K. S., J. F. Huang, J. Zhu, V. D'Agati, X. Liu, N. Miller, M. G. Erlander, M. R. Jackson, and R. J. Winchester. 2004. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J. Clin. Invest. 113: 1722-1733. (Pubitemid 39071664)
41. Pawar, R. D., P. S. Patole, D. Zecher, S. Segerer, M. Kretzler, D. Schlöndorff, and H. J. Anders. 2006. Toll-like receptor-7 modulates immune complex glomerulonephritis. J. Am. Soc. Nephrol. 17: 141-149.
42. Liu, J., G. Karypis, K. L. Hippen, A. L. Vegoe, P. Ruiz, G. S. Gilkeson, and T. W. Behrens. 2006. Genomic view of systemic autoimmunity in MRLlpr mice. Genes Immun. 7: 156-168. (Pubitemid 43336058)
43. Baccala, R., D. H. Kono, and A. N. Theofilopoulos. 2005. Interferons as pathogenic effectors in autoimmunity. Immunol. Rev. 204: 9-26. (Pubitemid 40460490)
44. Sato, M., N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi, and N. Tanaka. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441: 106-110. (Pubitemid 29012382)
45. Marié, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17: 6660-6669. (Pubitemid 28521799)
46. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658. (Pubitemid 44298214)
47. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226. (Pubitemid 41057736)
48. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
49. Asselin-Paturel, C., G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri. 2005. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201: 1157-1167. (Pubitemid 40528442)
50. Kerkmann, M., S. Rothenfusser, V. Hornung, A. Towarowski, M. Wagner, A. Sarris, T. Giese, S. Endres, and G. Hartmann. 2003. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170: 4465-4474. (Pubitemid 36519951)
51. Liao, A. P., M. Salajegheh, C. Morehouse, R. Nazareno, R. G. Jubin, B. Jallal, Y. Yao, and S. A. Greenberg. 2010. Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production. Clin. Immunol. 136: 130-138.
52. Amano, H., E. Amano, M. L. Santiago-Raber, T. Moll, E. Martinez-Soria, L. Fossati-Jimack, M. Iwamoto, S. J. Rozzo, B. L. Kotzin, and S. Izui. 2005. Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus. Arthritis Rheum. 52: 2790-2798. (Pubitemid 41369108)
53. Thibault, D. L., A. D. Chu, K. L. Graham, I. Balboni, L. Y. Lee, C. Kohlmoos, A. Landrigan, J. P. Higgins, R. Tibshirani, and P. J. Utz. 2008. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 118: 1417-1426. (Pubitemid 351500435)
54. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177. (Pubitemid 41586947)
55. Nacionales, D. C., K. M. Kelly-Scumpia, P. Y. Lee, J. S. Weinstein, R. Lyons, E. Sobel, M. Satoh, and W. H. Reeves. 2007. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum. 56: 3770-3783. (Pubitemid 350100710)
56. Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249. (Pubitemid 36749609)